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In a 25-year follow-up study of 44864 men with measured serum cholesterol levels, the testicular cancer hazard ratios for the serum
cholesterol categories 5.7–6.9 and X7.0mmoll
 1 vs the reference category (o5.7mmoll
 1) were 1.3 and 4.5, respectively; P-value
for trend¼0.005. This highly significant association suggests that high-serum cholesterol is a risk factor for testicular cancer.
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An increased cancer risk has been reported at both high (e.g.
To ¨rnberg et al, 1986; Yamada et al, 1998) and low (e.g. Eichholzer
et al, 2000) serum cholesterol concentrations. To our knowledge,
the relation between testicular cancer risk and serum cholesterol
has not been evaluated. Testicular cancer is the commonest cancer
site in men aged 15–44 years in Sweden as well as in many other
countries. The incidence of testicular cancer has increased in
recent decades although the incidence is relatively low, 5.8 per
100000 in Sweden 2002. Nondescended testes at birth and other
abnormal testicular developments are well-established risk factors
for testicular cancer (Scottenfeld and Fraumeni, 1996, pp 1213). An
ecological correlation between testicular cancer and fat consump-
tion has been demonstrated (Armstrong and Doll, 1975) and case–
control studies have also shown an increased risk associated with a
high intake of total fat, saturated fat, dietary cholesterol (Sigurdson
et al, 1999) and dairy products (Davies et al, 1996; Garner et al,
2003). We have investigated the relation between serum cholesterol
and testicular cancer using data from the Va ¨rmland cohort.
MATERIALS AND METHODS
Between 1963 and 1965 a mass screening health trial, ‘the
Va ¨rmland survey’, was conducted in Sweden for a large cohort
of 92710 individuals aged 17–74 years to identify early-stage
diseases in an unselected population (To ¨rnberg et al, 1989).
Among other measures, blood chemistry analysis including non-
fasting serum cholesterol was included in the survey. Earlier
findings based on the data from this cohort (To ¨rnberg et al, 1989)
accorded with results of other studies, such as the well-known
association between serum cholesterol level and coronary heart
disease.
The national registration system in Sweden using personal code
numbers for all residents makes it possible to link registries to one
another. Thus, the cohort data were matched with the Swedish
Cancer Registry and the Swedish Cause of Death Registry. Matched
data were examined for records of cancer registration and death
between 1958 and 1987, giving a 25-year period of follow-up. A
more detailed delineation of the cohort has been reported
elsewhere (To ¨rnberg et al, 1989).
Subjects with reported cancer (at any site) before they were
examined within the survey were excluded from the study
population. To avoid the possibility of incorrect conclusions
because of inverse causality, that is, that the result is a reflection of
preclinical testicular cancer, the cases that occurred within 2 years
from the start of the follow-up period were excluded. For statistical
analysis, Cox’s proportional hazard model was used, with months
from serum cholesterol test to testicular cancer event recorded as
the follow-up time variable. Observations with no cancer event
were censured at the time of death or end of the follow-up period.
Hazard ratio (HR) estimates with 95% confidence intervals (CI)
and two-tailed statistical tests of significance were computed using
the Cox’s regression model. In the analysis, serum cholesterol was
classified into three categories, namely, serum cholesterol level
o5.7, 5.7–6.9 and X7.0mmoll
 1. In the fitted regression model,
the cholesterol categories were treated as an indicator variable,
with the lowest category as a reference group. The regression
model was adjusted by age (5-year groups). A trend test was also
included in the analysis.
RESULTS
Among the 44864 men at risk in the cohort, there were 21 cases
of testicular cancer during the follow-up period. A positive
correlation between serum cholesterol level and testicular cancer
incidence was found and the estimated HRs for the middle and
highest serum cholesterol categories compared to the lowest was
1.3 (95% CI: 0.3–5.1) and 4.5 (95% CI: 1.3–16.2), respectively
(P¼0.005) (Table 1).
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Since high intake of saturated fat or meat is known to elevate the
serum cholesterol concentration (Thorogood et al, 1990), the
results corroborate the hypotheses advanced concerning a relation
between fat intake and testicular cancer (Armstrong and Doll,
1975; Davies et al, 1996; Sigurdson et al, 1999; Garner et al, 2003).
Nevertheless, the interpretation of the cholesterol–testicular
cancer association may be complicated by other influencing and
confounding factors. One example is under-nutrition, the essence
of the ‘foetal origins’ hypothesis, which suggests that several
adult diseases may be caused by under-nutrition in utero (Godfrey
and Barker, 2000). In conformity with this hypothesis, studies
have shown that high cholesterol levels (Davies et al, 2004) and
testicular cancer (Akre et al, 1996; Moller and Skakkebaek, 1997)
are associated with low birth weight. Available data suggest
that serum cholesterol concentration in Swedish men decreased
during the final decades of the past century (Jansson et al,
2003). Thus, changes in serum cholesterol concentration do
not explain the increasing incidence rate of testicular cancer in
recent decades.
In conclusion, the highly significant positive association
between serum cholesterol and testicular cancer risk found in this
population-based cohort study suggests that an elevated concen-
tration of serum cholesterol is a risk factor for testicular cancer.
However, since the finding is the first of its sort and because of the
wide CIs, more data from other cohorts are needed to confirm the
association.
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Table 1 Testicular cancer incidence in relation to serum cholesterol in a
25-year follow-up study of the Va ¨rmland cohort (n¼44864)
Serum cholesterol
categories
(mmoll
 1)
No. of
cases Hazard ratio
95% Confidence
interval
o5.7
a 3 1.0 —
5.7–6.9 7 1.3 0.3–5.1
X7.0 11 4.5 1.3–16.2
aReference category. P-value for the trend¼0.005.
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